Introduction
Macrocycles have found broad application in chemical biology, biotechnology and pharmaceutical research. [1] Over the last decade, particularly intense efforts have been channelled into the development of macrocycles and their use in the field of molecular recognition.
[2]
Nowadays, most synthetic compounds reported to interact with proteins are small molecules that bind to well-defined cavities on the protein structure. [3] More challenging, however, is the design of molecules with the ability to bind to the solvent-exposed protein surface and specifically recognize the large interfacial areas involved in protein-protein interactions, with the purpose of interfering in the functional activity of the target protein.
[4] The growing appreciation that these complex protein-protein interfaces appear to be 'undruggable' by small ligands has coincided with renewed interest in macrocycles, and cyclic peptides in particular, as potential protein binders, based on the premise that these cyclic molecules may be more suited to mimic natural biorecognition processes. [5] Cyclic peptides have a number of advantages over their linear counterparts. [6] For example, they show improved resistance to proteolytic degradation by exopeptidases due to the lack of both amino and carboxyl termini. Moreover, protein recognition is a conformation-dependent process, and converting linear sequences into their cyclized form is a common approach to modulate the performance of peptide sequences. A classic and elegant example is the chemical development of Cilengitide, a cyclic pentapeptide (c(Arg-GlyAsp-D-Phe-Val)) that is selective for αv integrins and that was under investigation for the treatment of glioblastoma. [7] Research on a variety of linear and cyclic penta-and hexapeptides containing the tripeptide sequence RGD (arginine, glycine and aspartic acid) showed that cycles inducing distinct conformations of RGD sequences were able to recognize various integrin receptors. [8] These pioneering studies showed that the preorganization of the crucial side chains by cyclization significantly affects the functional activity of the amino acid sequences. Both the binding affinity and the selectivity of a recognition motif introduced into a cyclic peptide may increase when its bioactive conformation is included in the restrained conformational space of the cyclic molecule. In this case, cyclization reduces the entropic penalty of binding, thereby improving the binding interaction. However, cyclization often results in a significant decrease or even a total loss of activity. [9] This occurs when the bioactive conformation of the recognition motif is excluded from the conformational space of the constrained peptide. It is also possible that, although accessible in the restricted conformational ensemble of the cycle, the bioactive conformation of the peptide is scarcely populated. Cyclic peptides still have considerable backbone mobility, but usually display rugged conformational landscapes that include a number of energy local minima that may not be uniformly sampled. Reaching some conformational states may involve the rare crossing of significant energy barriers.
Therefore, the cyclic molecule would thermally fluctuate among a subset of states at a given temperature. These crucial considerations should not be overlooked in screening projects based on "ligand-oriented design" strategies. The chances of finding suitable protein ligands will depend on the availability of a robust synthetic approach to generate a variety of diverse molecules, combined with detailed knowledge of the conformational behavior of the molecules generated.
Motivated by these observations, we sought to synthesize a small library of C2 symmetric cyclic hexapeptides of the type c(Xaa-D-Pro-Yaa)2 (Scheme 1 and Table S1 ). We hypothesized that this family of constrained cyclic peptides may have potential applications in the recognition of different types of protein surfaces. In fact, this library has recently demonstrated to be useful as a source of ligands able to recognize two completely unrelated proteins, such as the human vascular endothelial growth factor (VEGF) [10] and the bacterial OmpA. One OmpA inhibitor selected from this library was shown to prevent bacterial infection in an in vivo model. [11] Scheme 1. family of peptides is also described in detail in this study.
Results and Discussion
Design of the library of cyclic hexapeptides
Here we aimed to synthesize a family of cyclic peptides with a preorganized structural scaffold that could optimally present a set of side chains selected for their favorable properties for protein surface recognition. We focused on C2 symmetric cyclic hexapeptides due to their straightforward synthesis and because they adopt conformations featured by two fused β-turn arrangements.
[13] Initially, we synthesized a set of peptides of the type c(Xaa-D-Pro-Yaa)2 (Scheme 1, peptides 1-15) including a D-amino acid to enhance the β-turn propensity. [14] Xaa and Yaa could be Trp, Arg, Glu, Ser, Ala and Ile. These residues were rationally selected from all proteinogenic amino acids on the basis of the physicochemical, synthetic and statistical parameters considered in our previous work.
[ 15] Tryptophan was chosen because it is over-represented at protein interfaces and is found on many hot spots. [16]
The initial library was then expanded to include new peptides (peptides 16-31) (Scheme 1 and The observation of three individual spin systems in the NMR spectra of all four peptides confirmed the C2 symmetric nature of these molecules ( Figure S1 ). This observation is consistent with these peptides populating either a unique conformation or different states coexisting in fast equilibrium in the NMR timescale. A complete resonance assignment is provided in the Supporting Information (Table S2 ). The resemblance of structure-sensitive NMR parameters such as secondary chemical shifts, 3 JNHHα values, temperature coefficients of amide protons ( Table 1) . [17] The The NH amide protons of the Xaa and Yaa residues within this set of peptides exhibited a well-differentiated trend.
Irrespective of the chemical nature of the amino acid, the NH of Xaa residues showed higher-field chemical shifts (Table S2) . [20] The spatial proximity between the Trp and Pro side chains also pointed to the occurrence of CH-π interactions ( Figure S5b ). Therefore, an NMR-based conformational analysis of peptides 17 (LDD chirality) and 18 (DDL chirality) was conducted and the results were compared with those of peptide 7 (LDL chirality). A complete resonance assignment for these peptides is provided in the Supporting Information (Table S3) . signals coexisting with those of the two major species was also observed but they could not be assigned due to their lower intensity and to severe spectral overlap. A recent study [23] reported that a peptide with the enantiomeric chirality of (Table S4 and Figure S13 ).
The NMR-derived populations of conformers at 298 K are shown in Table 2 
[a] Peptides 19 and 24 could not be evaluated due to solubility restrictions.
[b] Minor conformation could not be unambiguously assigned due to very low signal intensity. and by D-Ala (peptide 28) ( Table S5) .
Removal of the aromatic side chain decreased the cis/cis content in both cyclic hexapeptides (Table 2) . Replacement of the aromatic residue by Ala had a drastic effect. In peptide 28 we observed only 10% of the two-cis conformer, the all-trans being the most abundant. However, when the aromatic residue was substituted by a bulky side chain, such as Ile (peptide 27), only a moderate decrease in the cis/cis content (from > 95% to 80%) was observed. These findings suggest that the cis Ψ= 160 o ) [17] . 
